Gamco Investors INC. ET AL trimmed its position in shares of Morgan Stanley (NYSE:MS) by 2.9% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 679,319 shares of the financial services provider’s stock after selling 20,000 shares during the period. Gamco Investors INC. ET AL’s holdings in Morgan Stanley were worth $29,761,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Qube Research & Technologies Ltd lifted its holdings in Morgan Stanley by 9.4% in the 2nd quarter. Qube Research & Technologies Ltd now owns 44,541 shares of the financial services provider’s stock valued at $1,951,000 after purchasing an additional 3,814 shares in the last quarter. LFA Lugano Financial Advisors SA acquired a new stake in shares of Morgan Stanley during the 2nd quarter worth about $66,000. Clarius Group LLC increased its position in shares of Morgan Stanley by 21.8% during the 2nd quarter. Clarius Group LLC now owns 11,327 shares of the financial services provider’s stock worth $496,000 after purchasing an additional 2,027 shares during the last quarter. Parkside Investments LLC acquired a new stake in shares of Morgan Stanley during the 2nd quarter worth about $704,000. Finally, Candriam Luxembourg S.C.A. increased its position in shares of Morgan Stanley by 3.5% during the 2nd quarter. Candriam Luxembourg S.C.A. now owns 146,813 shares of the financial services provider’s stock worth $6,404,000 after purchasing an additional 4,944 shares during the last quarter. 84.39% of the stock is owned by institutional investors and hedge funds.
MS has been the subject of several research reports. Citigroup raised Morgan Stanley from a “neutral” rating to a “buy” rating and lifted their target price for the company from $48.00 to $52.00 in a research report on Friday, July 12th. Royal Bank of Canada set a $60.00 price objective on Morgan Stanley and gave the company a “buy” rating in a research note on Wednesday, April 24th. BMO Capital Markets set a $69.00 price objective on Morgan Stanley and gave the company a “buy” rating in a research note on Friday, July 19th. ValuEngine cut Morgan Stanley from a “hold” rating to a “sell” rating in a research note on Monday, May 13th. Finally, TheStreet cut Morgan Stanley from a “b” rating to a “c+” rating in a research note on Wednesday, August 14th. Three analysts have rated the stock with a sell rating, three have issued a hold rating and ten have given a buy rating to the company. Morgan Stanley has a consensus rating of “Hold” and an average price target of $56.92.
Morgan Stanley (NYSE:MS) last issued its quarterly earnings data on Thursday, July 18th. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.13 by $0.10. Morgan Stanley had a return on equity of 11.04% and a net margin of 16.06%. The business had revenue of $10.24 billion for the quarter, compared to the consensus estimate of $10.02 billion. During the same period in the prior year, the business earned $1.30 earnings per share. The business’s revenue was down 3.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Morgan Stanley will post 4.78 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Wednesday, July 31st were given a dividend of $0.35 per share. The ex-dividend date of this dividend was Tuesday, July 30th. This is an increase from Morgan Stanley’s previous quarterly dividend of $0.30. This represents a $1.40 annualized dividend and a yield of 3.47%. Morgan Stanley’s dividend payout ratio is 30.37%.
Morgan Stanley Company Profile
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates through Institutional Securities, Wealth Management, and Investment Management segments.
Featured Article: Marijuana Stocks Future Looks Bright
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.